The MAHA commission's assessment of children's health mirrored RFK Jr.'s familiar targets. The question now is what remedies ...

The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...

As Hinge Health goes public, CEO Dan Perez tells STAT the goal is to automate physical therapy in any way it can.

The notion that we should require placebo trials even when there's already a safe, effective vaccine goes against decades of ...

Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...

The House Rules Committee passed the budget reconciliation bill late Wednesday night, teeing it up for House floor action.

His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...

Private equity ownership of psychiatric hospitals grew rapidly from 2013 to 2021, but the quality of care did not diminish ...

A “genetic surgery” or “interventional genetics” system for individualized treatments would be a marriage of drug development ...

A recovery from this prolonged and painful market downturn will require a major attitude adjustment from biotech management ...